Interestingly, TTR also regulates LRP1 levels, thus TTR promotes Aβ clearance at the BBB, directly, by assisting its elimination, and indirectly, by increasing the levels of the main Aβ efflux receptor, adding to the interest of using this protein as a therapeutic target in AD. The gene discussed is LRP1; the disease is Alzheimer disease.